ES2652253T3 - Preparación de vitamina - Google Patents
Preparación de vitamina Download PDFInfo
- Publication number
- ES2652253T3 ES2652253T3 ES13752596.0T ES13752596T ES2652253T3 ES 2652253 T3 ES2652253 T3 ES 2652253T3 ES 13752596 T ES13752596 T ES 13752596T ES 2652253 T3 ES2652253 T3 ES 2652253T3
- Authority
- ES
- Spain
- Prior art keywords
- vitamin
- skin
- vitamin preparation
- adenosylcobalamin
- polysorbate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
Abstract
Uso de un polisorbato en una preparación de vitamina para el tratamiento de estados de irritación de la piel y mucosas, conteniendo la preparación de vitamina una cantidad fisiológicamente activa de vitamina B12 o de otro precursor de adenosilcobalamina (coenzima B12), el polisorbato así como materiales de vehículo habituales para la configuración de una matriz de vehículo, como agente de arrastre para la introducción en las capas superiores de la piel de vitamina B12 o del otro precursor de adenosilcobalamina en la piel.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102012014581.0A DE102012014581A1 (de) | 2012-07-24 | 2012-07-24 | Vitaminzubereitung |
DE102012014581 | 2012-07-24 | ||
PCT/EP2013/065477 WO2014016277A2 (de) | 2012-07-24 | 2013-07-23 | Vitaminzubereitung |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2652253T3 true ES2652253T3 (es) | 2018-02-01 |
Family
ID=49029067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES13752596.0T Active ES2652253T3 (es) | 2012-07-24 | 2013-07-23 | Preparación de vitamina |
Country Status (6)
Country | Link |
---|---|
US (1) | US10973919B2 (es) |
EP (1) | EP2877153B1 (es) |
DE (1) | DE102012014581A1 (es) |
ES (1) | ES2652253T3 (es) |
PL (1) | PL2877153T3 (es) |
WO (1) | WO2014016277A2 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102016107563A1 (de) * | 2016-04-22 | 2017-10-26 | Sven Reichwagen | Vitaminzubereitung |
EP3552601A1 (de) * | 2018-04-11 | 2019-10-16 | Karl Bodenschatz | Pharmazeutische zusammensetzung enthaltend dexpanthenol und polihexanid |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE406167T1 (de) * | 2000-11-08 | 2008-09-15 | Fxs Ventures Llc | Verbesserte ophthalmologische und kontaktlinsenlösungen mit einer peroxidquelle und einem kationischen polymeren konservierungsmittel |
DE10147186A1 (de) * | 2001-09-25 | 2003-04-24 | Beiersdorf Ag | Wirkstoffkombinationen aus Polyhexamethylenbiguanid-Hydrochlorid und Distearyldimethylammoniumchlorid und Zubereitungen, solche Wirkstoffkombinationen enthaltend |
EP1435973A4 (en) * | 2001-09-28 | 2007-05-02 | Mayo Foundation | SIMULTANEOUS ADMINISTRATION OF A TRANSPORT PROTEIN WITH CONJUGATED COBALAMINE FOR THE DISTRIBUTION OF MEDICINAL PRODUCTS |
EP1730522A2 (en) * | 2004-03-29 | 2006-12-13 | Howard Murad | Methods for treating dermatological conditions in a patient |
US20080039422A1 (en) * | 2004-03-30 | 2008-02-14 | Transition Therapeutics Inc. | Vitamin B12-Containing Compositions and Methods of Use |
US20050238675A1 (en) * | 2004-04-26 | 2005-10-27 | Wenjie Li | Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications |
WO2005120256A2 (en) * | 2004-06-07 | 2005-12-22 | Biotec Films, Llc | Oral products |
KR100658436B1 (ko) * | 2005-12-09 | 2006-12-27 | 한국화학연구원 | 아데노실코발라민 함유 피부질환 치료용 외용제 조성물 |
EP2124907B1 (en) * | 2007-03-19 | 2018-05-30 | Vita Sciences, Llc | Transdermal patch and method for delivery of vitamin b12 |
CN101181289A (zh) * | 2007-11-28 | 2008-05-21 | 南京海陵中药制药工艺技术研究有限公司 | 一种13种复合维生素注射剂及其生产工艺 |
CN102048678A (zh) * | 2009-10-30 | 2011-05-11 | 北京隆旗生物科技有限公司 | 一种奥昔布宁的透皮吸收制剂及其制备方法与药物应用 |
CN101711769A (zh) * | 2009-11-23 | 2010-05-26 | 北京京卫信康医药科技发展有限公司 | 一种稳定的注射用12种复合维生素组合物及其制备方法 |
JP5603605B2 (ja) * | 2010-01-26 | 2014-10-08 | テルモ株式会社 | 鉄を含有しない微量元素配合輸液製剤 |
-
2012
- 2012-07-24 DE DE102012014581.0A patent/DE102012014581A1/de not_active Withdrawn
-
2013
- 2013-07-23 EP EP13752596.0A patent/EP2877153B1/de active Active
- 2013-07-23 PL PL13752596T patent/PL2877153T3/pl unknown
- 2013-07-23 US US14/417,288 patent/US10973919B2/en active Active
- 2013-07-23 WO PCT/EP2013/065477 patent/WO2014016277A2/de active Application Filing
- 2013-07-23 ES ES13752596.0T patent/ES2652253T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
EP2877153A2 (de) | 2015-06-03 |
DE102012014581A1 (de) | 2014-01-30 |
PL2877153T3 (pl) | 2018-04-30 |
WO2014016277A2 (de) | 2014-01-30 |
US10973919B2 (en) | 2021-04-13 |
EP2877153B1 (de) | 2017-09-13 |
WO2014016277A3 (de) | 2014-04-10 |
US20150366971A1 (en) | 2015-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2649340T3 (es) | Administración de fármacos activados por hipoxia y agentes antiangiogénicos para el tratamiento del cáncer | |
CL2018000706A1 (es) | Derivados de pirazolopirimidina como inhibidores btk para el tratamiento del cancer. | |
PE20211069A1 (es) | Composicion que comprende 5'-metilselenoadenosina, selenoadenosil-l-homocisteina y gama glutamil-metilselenocisteina | |
CL2014001792A1 (es) | Compuestos derivados de carbamato; composicion farmaceutica, y uso de los mismos en el tratamiento del dolor, cancer por tumor solido, obesidad, entre otras enfermedades. | |
CL2018000739A1 (es) | Terapia adjuntiva con 25-hidroxi vitamina d y artículos de la misma. | |
AR096402A1 (es) | Medicamento de metformina y dihidroquercetina | |
CL2016000008A1 (es) | Tratamiento de lesiones inflamatorias de rosacea con ivermectina. | |
PE20140255A1 (es) | Tableta dispersable en forma oral | |
CL2015002835A1 (es) | Nuevos derivados de piridina | |
DOP2015000071A (es) | Fármaco combinado que comprende gemigliptina y metformina, y método para su preparación | |
BR112021017878A2 (pt) | Carbonato de magnésio com superfície reagida, sistema de liberação, formulação de cuidados domiciliares, métodos para preparar um carbonato de magnésio com superfície reagida e para preparar um sistema de liberação, e, uso de um carbonato de magnésio com superfície reagida e de um sistema de liberação | |
ECSP15022442A (es) | Producto de comicronización que comprende acetato de ulipristal | |
UY36202A (es) | Composición farmacéutica que comprende hemoglobina recombinante o un agente terapéutico basado en subunidades para el tratamiento de cáncer | |
BR112022000982A2 (pt) | Forma de dosagem veterinária mastigável macia | |
BR112015029894A2 (pt) | forma de dosagem farmacêutica sólida | |
ES2616035T3 (es) | Preparación para su uso en la profilaxis y el tratamiento de osteoporosis atípica | |
ES2659519T3 (es) | Método para producir medicamentos para combatir tumores | |
ES2609817T3 (es) | Leucotoxina E/D como nuevo agente antiinflamatorio y microbicida | |
ES2652253T3 (es) | Preparación de vitamina | |
NI201000181A (es) | Utilización de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administración de dronedarona. | |
ES2811674R1 (es) | Compuestos de ácido ascórbico y quinona en combinación con un agente antiparasitario para el tratamiento de una enfermedad parasitaria | |
AR094224A1 (es) | Composicion farmaceutica en forma de una suspension oral | |
CL2019003288A1 (es) | Una combinación farmacéutica para el tratamiento de un cáncer. | |
ES2535528T3 (es) | Composición para el tratamiento externo de cadáveres | |
ECSP15033649A (es) | Un medicamento combinado que comprende fenilefrina y paracetamol |